Israel approves military takeover of Gaza City, escalating 22-month conflict with Hamas and raising concerns over hostages and humanitarian crisis.
U.S. doubles reward for Maduro, citing 'narco-state' as Venezuela's leader remains openly in the country.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
Israel approves military takeover of Gaza City, escalating 22-month conflict with Hamas and raising concerns over hostages and humanitarian crisis.
U.S. doubles reward for Maduro, citing 'narco-state' as Venezuela's leader remains openly in the country.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.